The prevalence of women who had a positive screen for PPD at 6 weeks postpartum was 16% in our study. This rate is in agreement with many prevalence studies [7] and confirms that one in six new ...

A new mom shares how the recently approved two-week postpartum depression drug was a game-changer to combat a notably common condition during a tender phase of life.

Editor’s Note: This article was revised in May 2024 to reflect newly available peripartum mental health data and the 2023 ACOG clinical practice guideline pertaining to screening for mental health ...

A new iPhone app launched for free by Massachusetts General Hospital (MGH) looks not only to bring convenient postpartum depression (PPD) screening to more expecting and postpartum women, but also ...

After giving birth, new mothers typically return for a follow-up appointment six to eight weeks later. But if postpartum depression symptoms emerge, “that can be a really long time for someone who is ...

A woman's risk of developing postpartum depression is influenced by several pain-related factors before and after childbirth, including poor pain management, their prenatal mental health and the ...

Disrespectful maternity care during childbirth and/or postpartum affected nearly 1 in 4 women, and this experience was associated with an increased risk for postpartum depression symptoms at 2 months.

Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.

Over the course of her career, Susana Carmona, a clinical psychologist and neuroscientist at the Gregorio Marañón Institute of Health Research, has used brain imaging to study the distinctive brain ...